StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3029% below fair value
$6.70−0.31 (-4.42%)

Close on Nov 20, 2026Market cap $126.20MP/E 27.9Yield –

OptimizeRx gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

OptimizeRx's gross profit for the twelve months ending Jun 30, 2026 was $72.24M, up 7.1% year over year. For fiscal 2025 it was $73.60M, up 23.9% from the year before. Over ten years it grew 35.2% a year on average. The highest annual figure on record is $73.60M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$73.60M+23.9%
FY2024Dec 31, 2024$59.38M+38.4%
FY2023Dec 31, 2023$42.90M+10.1%
FY2022Dec 31, 2022$38.97M+9.3%
FY2021Dec 31, 2021$35.64M+47.8%
FY2020Dec 31, 2020$24.11M+56.1%
FY2019Dec 31, 2019$15.44M+26.5%
FY2018Dec 31, 2018$12.21M+105.1%
FY2017Dec 31, 2017$5.95M+37.2%
FY2016Dec 31, 2016$4.34M+20.6%
FY2015Dec 31, 2015$3.60M+9.7%
FY2014Dec 31, 2014$3.28M+16.4%
FY2013Dec 31, 2013$2.82M+50.4%
FY2012Dec 31, 2012$1.87M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$15.69M-15.8%
Q1 FY2026Mar 31, 2026$14.93M+11.9%
Q4 FY2025Dec 31, 2025$24.10M+9.4%
Q3 FY2025Sep 30, 2025$17.52M+30.3%
Q2 FY2025Jun 30, 2025$18.64M+59.2%
Q1 FY2025Mar 31, 2025$13.34M+9.3%
Q4 FY2024Dec 31, 2024$22.02M+23.4%
Q3 FY2024Sep 30, 2024$13.45M+37.2%
Q2 FY2024Jun 30, 2024$11.70M+49.6%
Q1 FY2024Mar 31, 2024$12.20M+64.2%
Q4 FY2023Dec 31, 2023$17.84M+43.3%
Q3 FY2023Sep 30, 2023$9.80M+21.0%
Q2 FY2023Jun 30, 2023$7.83M-36.9%
Q1 FY2023Mar 31, 2023$7.43M-18.1%
Q4 FY2022Dec 31, 2022$12.45M+54.8%
Q1 FY2022Mar 31, 2022$8.10M+32.3%
Q4 FY2021Dec 31, 2021$12.39M+44.0%
Q3 FY2021Sep 30, 2021$9.08M+50.9%
Q2 FY2021Jun 30, 2021$8.04M+56.4%
Q1 FY2021Mar 31, 2021$6.12M+41.0%
Q4 FY2020Dec 31, 2020$8.60M+99.2%
Q3 FY2020Sep 30, 2020$6.01M+65.9%
Q2 FY2020Jun 30, 2020$5.14M+25.7%
Q1 FY2020Mar 31, 2020$4.34M+38.0%
Q2 FY2019Jun 30, 2019$4.32M+50.9%
Q1 FY2019Mar 31, 2019$3.63M+72.3%
Q4 FY2018Dec 31, 2018$4.09M+62.2%
Q3 FY2018Sep 30, 2018$3.15M+124.9%
Q2 FY2018Jun 30, 2018$2.86M+127.1%
Q1 FY2018Mar 31, 2018$2.10M+173.1%
Q4 FY2017Dec 31, 2017$2.52M+77.7%
Q3 FY2017Sep 30, 2017$1.40M+31.6%
Q2 FY2017Jun 30, 2017$1.26M+27.2%
Q1 FY2017Mar 31, 2017$770.34K-11.1%
Q4 FY2016Dec 31, 2016$1.42M–
Q3 FY2016Sep 30, 2016$1.06M–
Q2 FY2016Jun 30, 2016$990.47K–
Q1 FY2016Mar 31, 2016$866.74K–

More OptimizeRx figures

See a number that looks wrong?